Does J9025 require prior authorization?

Yes, J9025 requires prior authorization (high confidence). At least one active policy explicitly requires prior authorization.

What is the Medicare reimbursement rate for J9025?

Medicare facility rate: N/A. Non-facility rate: N/A. Work RVU: 0.00.

HCPCS/CPT

Prior Auth Required

At least one active policy explicitly requires prior authorization (high confidence)

Work RVU

0.00

Facility

N/A

Non-Facility

N/A

Juvenile myelomonocytic leukemia (JMML): azacitidine/ Vidaza is indicated for treatment of pediatric patients aged 1 month and older with newly diagnosed juvenile myelomonocytic leukemia (JMML).

HEALTHNET_OR-HNOR-AZACITIDINE-ONUREG-VIDAZA-CP-PHAR-387-60EF3EB350, Azacitidine (Onureg, Vidaza); CP.PHAR.387

Ask Backwork about documentation requirements, denial risks, or coverage in your state.